# Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?

> **NCT01093755** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 30 (actual)

## Conditions studied

- Inflammation
- Barrett's Esophagus

## Interventions

- **DRUG:** dexlansoprazole
- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT01093755
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01093755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01093755, "Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01093755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*